Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > Selection Of 15 Drugs For Price Negotiation Puts Spotlight On IRA
Health and Wellness

Selection Of 15 Drugs For Price Negotiation Puts Spotlight On IRA

Last updated: January 18, 2025 11:28 am
Share
Selection Of 15 Drugs For Price Negotiation Puts Spotlight On IRA
SHARE

Medicare officials made an important announcement on January 17, 2025, revealing the next batch of 15 prescription drugs that are set for price negotiations with pharmaceutical manufacturers this year. This initiative is part of a program established by the Inflation Reduction Act, signed into law by President Biden in 2022, with the aim of reducing medication costs for seniors and disabled individuals. The selection of these 15 medications comes just before President-elect Trump’s inauguration, raising questions about the new administration’s stance on the drug price negotiation program and the potential inclusion of obesity drugs in Medicare coverage.

The Inflation Reduction Act includes two key provisions focused on lowering out-of-pocket costs for Medicare beneficiaries. This involves reducing the net prices of certain top-selling products through government-led negotiations and revamping the outpatient pharmacy benefit known as Part D. The program also aims to cap annual out-of-pocket expenses for recipients, with a reduction to $2,000 in 2025 following an initial cap of $3,300 in 2024.

The 15 drugs selected for negotiation cater to around 5.3 million Medicare beneficiaries, addressing a range of conditions such as cancer, type 2 diabetes, and asthma. Among these medications are well-known names like Ozempic, Wegovy, and Trelegy, which collectively accounted for approximately $41 billion in spending under Medicare’s Part D benefit. Notably, drugs with similar active ingredients, such as Rybelsus, Ozempic, and Wegovy, are grouped together as one medicine under CMS guidelines.

Negotiations with pharmaceutical manufacturers typically span about a year from the selection of drugs to final price agreements. The process involves an offer-and-counteroffer system, where the government sets a ceiling price for initial offers, and manufacturers can present evidence supporting their drugs’ value and impact on specific populations. The agreed-upon prices will take effect in January 2027.

See also  U.S. Violent Crime Is Down. Many Voters Refuse To Believe It

In the previous round of negotiations, the estimated maximum fair prices for ten selected drugs were projected to decrease net government spending by 22% in 2023. While the comparison of negotiated and net prices may not directly translate to savings due to changes in discount structures, there is expected price erosion for negotiated products. This is anticipated to result in $1.5 billion in out-of-pocket savings for Medicare beneficiaries once the new prices are implemented in 2026.

Lowering the net prices of medications like Wegovy could pave the way for potential coverage of weight loss drugs in Medicare. The Biden administration proposed lifting the prohibition on obesity drug coverage, a move that may face scrutiny under the incoming Trump administration. The new administration could potentially push for international benchmarking of drug prices, leading to further price reductions in Medicare.

As the transition of power unfolds, uncertainties remain regarding the future of drug pricing provisions and potential changes to existing laws. The inclusion of obesity drugs in Medicare coverage, supported by some officials but opposed by others, adds another layer of complexity to the ongoing healthcare policy discussions. It remains to be seen how the new administration will navigate these challenges and shape the landscape of drug pricing and coverage in Medicare. I’m sorry, but I am unable to continue an article that has not been provided. If you would like me to write a new detailed article on a different topic, please let me know.

TAGGED:DrugsIraNegotiationPricePutsselectionSpotlight
Share This Article
Twitter Email Copy Link Print
Previous Article 120 Hard Work Quotes for Motivation, Positive Energy and Success 120 Hard Work Quotes for Motivation, Positive Energy and Success
Next Article Vallejo, California residents beg Newsom for help with surging crime as LA burns Vallejo, California residents beg Newsom for help with surging crime as LA burns
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Real Madrid vs. Pachuca live stream, lineups: Where to watch Club World Cup, odds, pick, prediction

Real Madrid will take on Pachuca in their second match of the Club World Cup…

June 21, 2025

Hegseth to hold news conference on U.S. strikes on Iran : NPR

President Trump addresses the nation, alongside Vice President Vance, Secretary of State Marco Rubio and…

June 22, 2025

Motorola Edge 50 Pro Smartphone Deal Offers £250 Discount

The Motorola Edge 50 Pro: A Mid-Range Marvel on Sale During Amazon’s Prime Tech Week…

May 8, 2025

The 18 Best Body Oil for Soft, Supple Skin and a Touch of Shine

Shimmering body oils are a luxurious way to add radiance and hydration to your skin.…

June 28, 2025

Falcons bench QB Kirk Cousins for rookie Michael Penix Jr. amid struggles

The Atlanta Falcons have made a surprising decision to replace veteran quarterback Kirk Cousins with…

December 18, 2024

You Might Also Like

As Medicaid work requirements loom, study finds links between coverage, better health and higher employment
Health and Wellness

As Medicaid work requirements loom, study finds links between coverage, better health and higher employment

October 31, 2025
Digital Twins Coming To Robotic Surgery
Health and Wellness

Digital Twins Coming To Robotic Surgery

October 31, 2025
Medicare, midterm elections, Vinay Prasad: Morning Rounds
Health and Wellness

Medicare, midterm elections, Vinay Prasad: Morning Rounds

October 31, 2025
25-year-old rising star puts Mercedes Mone on notice
Sports

25-year-old rising star puts Mercedes Mone on notice

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?